Advancing Cancer Vaccine Development through CRISPR/Cas9 Technologies and Future Opportunities
The advent of CRISPR/Cas9 genome editing has revolutionized the cancer immunotherapy market, offering unprecedented precision and versatility in the development of next-generation cancer vaccines.